Cary Pfeffer, M.D., serves as board chairman of Faze Medicines and as a partner at Third Rock Ventures since 2007. He has over 25 years of leadership experience in the biotech industry and served in several management and executive level roles at Biogen in product development, business development and international commercial roles. Cary has led several biotech companies launched out of TRV and has played an instrumental role in a number of innovative alliances, including an industry-leading global strategic collaboration between Agios and Celgene. He currently serves on the board of several companies, including Casma Therapeutics, Jounce Therapeutics, Rheos Medicines and Tango Therapeutics. Cary received his M.D. from the University of Pennsylvania, his MBA from the Wharton School of Business at the University of Pennsylvania and his B.A. in biochemistry from Columbia University.